Basics |
Company: |
Chimerix, Inc. |
IPO Date: |
April 11, 2013 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$300.39M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.27 | 2.92%
|
Avg Daily Range (30 D): |
$0.12 | 4.40%
|
Avg Daily Range (90 D): |
$0.06 | 3.47%
|
Institutional Daily Volume |
Avg Daily Volume: |
.75M |
Avg Daily Volume (30 D): |
6.57M |
Avg Daily Volume (90 D): |
2.33M |
Trade Size |
Avg Trade Size (Sh.): |
194 |
Avg Trade Size (Sh.) (30 D): |
293 |
Avg Trade Size (Sh.) (90 D): |
295 |
Institutional Trades |
Total Inst.Trades: |
857 |
Avg Inst. Trade: |
$1.36M |
Avg Inst. Trade (30 D): |
$.93M |
Avg Inst. Trade (90 D): |
$.93M |
Avg Inst. Trade Volume: |
.14M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.45M |
Avg Closing Trade (30 D): |
$.84M |
Avg Closing Trade (90 D): |
$.84M |
Avg Closing Volume: |
148.38K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-.94
|
$-.26
|
$-.23
|
Diluted EPS
|
$-.94
|
$-.26
|
$-.23
|
Revenue
|
$ .16M
|
$ .03M
|
$ .13M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -83.59M
|
$ -22.88M
|
$ -20.69M
|
Operating Income / Loss
|
$ -92.83M
|
$ -24.79M
|
$ -22.83M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 9.53M
|
$ 7.99M
|
$ -3.37M
|
PE Ratio
|
|
|
|
Splits |
Jun 23, 2006:
1:25
|
|